Keyphrases
Pathophysiology
100%
Nonalcoholic Steatohepatitis
100%
Incretin-based Drugs
100%
Cirrhosis
25%
Hepatocellular Carcinoma
25%
Coronary Artery Disease
25%
Drug Therapy
25%
Non-alcoholic Fatty Liver Disease (NAFLD)
25%
Oxidative Stress
25%
Molecular Mechanism
25%
Liver Cell Damage
25%
Common Complications
25%
Therapeutic Management
25%
Antidiabetic Drugs
25%
Novel Class
25%
Dipeptidyl peptidase-4 (DPP-4)
25%
Type 2 Diabetes Complications
25%
Hepatic Inflammation
25%
Severe Manifestations
25%
Therapy Research
25%
Glucagon-like peptide-1 Receptor (GLP-1R)
25%
GLP-1 Analogue
25%
Medicine and Dentistry
Atherosclerosis
100%
Pathophysiology
100%
Nonalcoholic Fatty Liver
100%
Incretin
100%
Glucagon Like Peptide 1
40%
Maturity Onset Diabetes of the Young
20%
Liver Cirrhosis
20%
Drug Therapy
20%
Coronary Artery Disease
20%
Liver Cell Damage
20%
Hepatocellular Carcinoma
20%
Antidiabetic Agent
20%
Oxidative Stress
20%
Therapeutic Management
20%
Pharmacology, Toxicology and Pharmaceutical Science
Pathophysiology
100%
Nonalcoholic Fatty Liver
100%
Atherosclerosis
100%
Incretin
100%
Glucagon-Like Peptide-1
40%
Inflammation
20%
Liver Cell Carcinoma
20%
Liver Cirrhosis
20%
Pharmacotherapy
20%
Antidiabetic Agent
20%
Liver Cell Damage
20%
Coronary Artery Disease
20%
Non Insulin Dependent Diabetes Mellitus
20%